Wird geladen...
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
BACKGROUND: Semaglutide, a glucagon-like peptide-1 (GLP-1) analogue, has been co-formulated with the absorption enhancer sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC) as a tablet for oral administration. This trial (NCT02014259) investigated the pharmacokinetics, safety and tolerability of...
Gespeichert in:
| Veröffentlicht in: | Clin Pharmacokinet |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer International Publishing
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6267549/ https://ncbi.nlm.nih.gov/pubmed/29623579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-018-0649-2 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|